Factors Associated With All-Cause Mortality Among Patients With Multidrug-Resistant Tuberculosis—United States, 1993–2013
Author(s) -
Jorge Salinas,
Lori Armstrong,
Benjamin J. Silk,
Maryam B. Haddad,
J. Peter Cegielski
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix667
Subject(s) - medicine , tuberculosis , demographics , mortality rate , multiple drug resistance , cause of death , human immunodeficiency virus (hiv) , demography , drug resistance , immunology , disease , pathology , sociology , microbiology and biotechnology , biology
We assessed characteristics associated with all-cause mortality among US patients with multidrug-resistant tuberculosis. Mortality decreased from 31% during 1993-2002 to 11% during 2003-2013. Directly observed therapy coverage increased from 74% to 95% and was protective against all-cause mortality after accounting for demographics, clinical characteristics, human immunodeficiency virus status, and period of treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom